Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease.

9 Oct 2019

Abstract excerpt

Huntington's disease (HD) has traditionally been described as a disorder purely of the brain; however, evidence indicates that peripheral abnormalities are also commonly seen. Among others, severe unintended body weight loss represents a prevalent and often debilitating feature of HD pathology, with no therapies available. It correlates with disease progression and significantly affects the quality of life of HD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to Genetic Neurodegenerative Diseases
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31630202
DOI: 10.1093/hmg/ddz247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease.PMID 31630202Read ↗

Curcumin modulates cell death and is protective in Huntington's disease model.Semantic proximity Read ↗

Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.Semantic proximity Read ↗

Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's DiseaseSemantic proximity Read ↗

XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age- and sex- dependent.Semantic proximity Read ↗

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.Semantic proximity Read ↗

Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation.Semantic proximity Read ↗

Idebenone and Resveratrol Extend Lifespan and Improve Motor Function of HtrA2 Knockout MiceSemantic proximity Read ↗

Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathwaySemantic proximity Read ↗

The role of calorie restriction and SIRT1 in prion-mediated neurodegenerationSemantic proximity Read ↗

Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington’s diseaseSemantic proximity Read ↗

Plants and phytochemicals for Huntington′s diseaseSemantic proximity Read ↗

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.